Home/ Supplements/ St Johns Wort/ Hi-Potency St. John's Wort 300 mg

Hi-Potency St. John's Wort 300 mg

product on market Capsule VQ Verified Quality Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Hi-Potency St. John's Wort 300 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
90
Servings
Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 300.0mg (240 products) 20 studies — no high-quality reviews

Other Ingredients

Vegetable Cellulose Capsule Silicated Cellulose Silica Leucine
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Recommendations: 2 capsules 2 to 3 times daily, or as directed by your healthcare professional.

Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN

USE ONLY IF SAFETY SEAL IS INTACT

Warning: If pregnant or taking oral contraceptives, consult your physician before taking.

Formulation Notes

CONTAINS NO COATINGS, BINDERS, YEAST, WHEAT, GLUTEN, MILK/DAIRY, CORN PROTEIN, SOY PROTEIN, EGGS, SUGAR, HYDROGENATED OIL, ARTIFICIAL COLORING, ARTIFICIAL FLAVORING OR PRESERVATIVES.

Additional Information

store sealed in a cool dry place

PLEASE RECYCLE

MADE IN THE USA

Doctor/Pharmacist Formulated

VQ

Independently tested for authenticity, potency, heavy metals, solvent residue, herbicide & pesticide residue, aflatoxins, stability and bacteria, yeast and mold counts.

REV. 113

Metadata

Product Details

UPC / SKU6 93465 22312 3
DSLD Entry Date2014-06-25
Product TypeBotanical
FormCapsule
DSLD ID33942
Data Updated2026-04-11
Research

Research Evidence

43
Research Sources
48
Avg Quality
16
Meta Analysis
14
Systematic Review
7
Rct
4
Regulatory Source
1
Clinical Trial
1
Openfda Safety
B St John's wort for major depression
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
B Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis
Meta Analysis Journal of affective disorders 2017 PubMed DOI
B A systematic review of St. John's wort for major depressive disorder
Meta Analysis Systematic reviews 2016 PubMed DOI
B St John's wort for depression
Systematic Review The Cochrane database of systematic reviews 2000 PubMed
B Efficacy of Pharmacological Interventions in Milder Depression: A Systematic Review and Meta-Analysis
Meta Analysis Neuropsychopharmacology reports 2025 PubMed DOI
B St John's wort for depression
Meta Analysis The Cochrane database of systematic reviews 2005 PubMed
C St John's wort for depression: meta-analysis of randomised controlled trials
Meta Analysis The British journal of psychiatry : the journal of mental science 2005 PubMed
C The effect of Hypericum perforatum on postmenopausal symptoms and depression: A randomized controlled trial
Rct Complementary therapies in medicine 2019 PubMed DOI
C Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks
Rct BMJ (Clinical research ed.) 1999 PubMed
C Hypericum perforatum as a cognitive enhancer in rodents: A meta-analysis
Meta Analysis Scientific reports 2016 PubMed DOI
View all evidence for St Johns Wort →
Compare

Similar Products

View all St Johns Wort products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.